Parlin, NJ, United States of America

Rita Colella


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovations of Rita Colella: A Pioneer in Biochemistry**

Introduction

Rita Colella, based in Parlin, NJ, is a distinguished inventor recognized for her contributions to the field of biochemistry, particularly in the isolation of cDNA clones related to cystatin. With a remarkable portfolio of two patents, her work has significantly advanced our understanding of proteinase inhibitors derived from chicken egg whites.

Latest Patents

Colella's latest patents focus on cDNA clones encoding chicken egg white cystatin. These innovations involve the isolation of cDNA clones coding for the chicken cysteine proteinase inhibitor cystatin. Utilizing a synthetic oligonucleotide probe corresponding to amino acids 81-90 of the cystatin sequence, she successfully screened a lambda gt 11 chicken oviduct cDNA library. This meticulous approach also led to the isolation of a full-length cystatin cDNA, emphasizing her innovative methods in genetic research.

Career Highlights

Throughout her career, Rita Colella has held positions at notable institutions, including the University of Kansas and Rutgers, the State University of New Jersey. Her tenure in these prestigious universities has allowed her to collaborate with leading researchers and contribute to significant scientific advancements.

Collaborations

In her journey as an inventor, Rita has worked alongside accomplished professionals such as Hideaki Nagase. This collaboration not only enhanced her research capabilities but also contributed to the innovative output of their projects.

Conclusion

Rita Colella's contributions to the field of biochemistry through her patents and collaborations are a testament to her inventive spirit and dedication to scientific research. Her work continues to inspire future innovations in the study of proteinase inhibitors and cDNA technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…